Shaun R Opie

Title: Shaun R Opie: Innovator in Genetic Modification Technologies

Introduction

Shaun R Opie is a notable inventor based in Phoenix, AZ (US). He has made significant contributions to the field of genetic modification, particularly through his innovative work on recombinant adeno-associated viral (rAAV) vectors. His research has implications for therapeutic applications in various medical fields.

Latest Patents

Shaun R Opie holds 1 patent for his invention titled "Raav expression systems for genetic modification of specific capsid proteins." This patent discloses improved rAAV vectors that feature mutations in one or more capsid proteins. The vectors have altered affinity for heparin or heparin sulfate, and some lack functional VP2 protein expression while remaining fully virulent. The invention also includes rAAV vector-based compositions, virus particles, host cells, and pharmaceutical formulations that are useful in expressing selected therapeutic proteins, polypeptides, peptides, antisense oligonucleotides, and ribozymes in selected mammals.

Career Highlights

Shaun R Opie is associated with the University of Florida Research Foundation Inc., where he continues to advance his research in genetic engineering. His work has garnered attention for its potential to improve therapeutic outcomes in various diseases.

Collaborations

Throughout his career, Shaun has collaborated with esteemed colleagues such as Kenneth H Warrington and Nicholas Muzyczka. These collaborations have further enriched his research and contributed to the advancement of genetic modification technologies.

Conclusion

Shaun R Opie's innovative work in the field of genetic modification exemplifies the impact of modern science on therapeutic development. His contributions continue to pave the way for advancements in medical treatments and genetic research.